I’m a doctor, and it’s hard to argue with the cost.
That’s why I was happy to see that the insurance company was going to allow people to get health insurance for the first time with the introduction of the BioselectIVE beta blocker.
That is a huge victory for me.
The only reason I didn’t think it would be more widespread is that the company has been lobbying for this.
I don’t think the FDA will allow BioseLECTIVE to be marketed until the drug is approved by the FDA, but there are people in Congress who are willing to vote for it.
So I’m hoping that it’ll pass.
I know the industry’s already been doing a lot of lobbying.
If the FDA approves BioseECTIVE, they’ll have a huge incentive to make it affordable.
If they can get the approval, they could also make it available to people who can’t afford insurance because of preexisting conditions.
That would be a big step forward.
We could see a lot more people being able to get the drug, and that would be great.
But we don’t know if that would happen before the FDA decides whether to approve it.
I’m happy to hear it will be approved.
In the meantime, I can say that the American Academy of Family Physicians has recommended BioseYSlectIVE to patients who can afford the $400 co-pay.
That means there are a lot less people who are getting the drug.
I hope that the drug will be on the market before the end of the year, and if it does, I will be happy to share the news with you.
It will be available from drugstore chains.
I do think that it’s going to be a game changer, and we’ll have to see how it pans out, because this is a big issue.
If it does work, it could actually be the catalyst that makes insurance more affordable.